Researchers surveyed more than 1,100 teenage drivers and found cell phones are a big distraction behind the wheel – even though many are aware of the danger to themselves and others.
Top 3 Medical Emergencies At School
A new study identifies three medical emergencies that account for the most EMS calls at schools. Researchers recommend improved training for these target areas.
Childhood Obesity in the U.S. Continues to Rise
A new study finds obesity in kids 2 to 19 years of age increased significantly between 2011 and 2023, and the COVID-19 pandemic was not a main driver.
Regular Exercise Helps Ease Kids’ Depression and Anxiety
A new study finds exercise decreases symptoms of depression and anxiety in children and teens – and may offer an alternative to antidepressants.
Low Levels of A Common Drinking Water Contaminant Linked to Premature Birth
In a new study, nitrate levels well below the EPA limit for drinking water were associated with an increased risk of premature birth and low-birthweight babies.
New Vaccine Committee To Review Long-Approved Shots. HealthDay Talks To Vaccine Expert and Former ACIP Member, Bonnie Maldonado, MD, About The New Agenda
Hi, I’m Andy Meyers, CEO of HealthDay. Thanks for joining us for HealthDay Now. On June 9th, the U.S. Department of Health and Human Services took what they call the bold step in restoring public trust by totally reconstructing the Advisory Committee for Immunization Practices, ACIP. They removed 17 of their existing members, placing them […]
Nearly 20% of Packaged Foods Sold in the U.S. Contain Synthetic Dyes
A review of the ingredients in 39,000+ packaged foods and drinks sold in the U.S. reveals many contain synthetic dyes, especially products marketed to kids.
Menstrual Cycle Linked to Increased Alcohol Cravings and Drinking
A new study suggests ovarian hormone fluctuations may contribute to alcohol craving and drinking.
GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds
In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.